Novel mutation of the notch3 gene in arabic family with CADASIL by Bohlega, Saeed
Neurology International 2011; volume 3:e6
Novel mutation of the notch3
gene in arabic family with
CADASIL
Saeed Bohlega
Department of Neurosciences, King Faisal
Specialist Hospital and Research Centre,
Riyadh, Saudi Arabia
Abstract 
Mutations in the NOTCH3 gene are respon-
sible for cerebral autosomal dominant arteri-
opathy with subcortical infarcts and leukoen-
cephalopathy  (CADASIL),  an  adult  onset
hereditary  angiopathy  leading  to  ischemic
stroke, vascular dementia and psychiatric dis-
orders. All mutation of NOTCH3 described so
far are striking stereotyped leading to the gain
or loss of cystiene residue in a given epidermal
growth factor (EGF), like repeat. We report an
Arabic family affected with CADASIL mutation,
G1790  C,  in  Exon  11  of  the  NOTCH3  gene.
This  is  the  first  novel  mutation  reported  in
Arabic  CADASIL  patients.  This  finding  con-
firms that mutations in NOTCH3 are associat-
ed with the pathogenesis of CADASIL across
different ethnic background.
Introduction
CADASIL is an autosomal dominant vascular
disorder clinically characterized by a variety of
symptoms including migraine with aura, mood
disorder, vascular dementia, ischemic stroke
and premature death.1-3 The vascular lesions
underlying CADASIL are a non-arteriosclerotic,
non-amyloid arteriopathy affecting small cere-
bral  arteries  with  accumulating  of  granular
and osmiophilic materials within the smooth
muscles cell basement membrane.4,5 This ini-
tial thickening and expansion of the extracel-
lular matrix can be found to a lesser extent in
extra cerebral arteries such as skin arterioles.5
Mutation  in  the  NOTCH3  gene  is  usually
linked to CADASIL.6 NOTCH3 encodes a 300-kd
transmembrane  protein  with  a  receptor  and
cell  signal  transduction  function.  Mutations
are in majority mis-sense mutations causing
the loss or gain of a cysteine residue and are
detected in 95% of patients.7 All mutations are
located  within  the  epidermal  growth  factor
(EGF) repeats in the extra cellular domain of
the NOTCH3 gene and a strong clustering of
the mutation were observed in Exon 3 and 4.8,9
Thus, there are more than 150 mutation have
been identified. (The human gene mutation
database  www.hgmd.org),  CADASIL  is  far
more common than previously perceived and it
may  often  be  misdiagnosed  because  it  can
present  under  various  guises.10 It  also  has
been  described  in  most  ethnic  groups  from
Western  &  Central  Europe,  Japan,  Turkey,
South Africa and South East Asia11,12 and only
few reported families from Arabic origin.13,14
Hence, we described for a first time, a native
Arabian family with CADASIL which harbor a
novel mutation in NOTCH3 genes.
History
The  family  is  a  native  Arabian  family  of
Bedouins  (Nomads)  origin  settled  in  North-
Eastern part of the Arabian peninsulas.
The proband is a male seen at age of 37
years with 2 years history of recurrent throb-
bing  headache  with  visual  aura,  and  four
months history repeated attacks of numbness
in left side. These attacks suggestive of TIA, he
is  smoker,  otherwise,  no  systemic  disorder.
His neurological examination was not reveal-
ing.  His mother died at age 52 after 7 years
history  of  repeated  strokes  and  dementia
(Figure 1). One brother had 2 strokes at age 35
years.  He  was  depressed  with  hyperreflexia
and right hemiparesis. Maternal grandfather
also died at mid fifties with history of strokes
and  dementia.  One  younger  sister  suffered
from migraine started at age 32 years and her
neurological  exam  was  normal.    None  had
hypertension or diabetes and all blood test and
cardiac evaluations were normal.
MRI brain of the index a case and his broth-
er,  sister  and  mother  showed  multiple  deep
white matter lesions (Figure 2) in temporal
and periventricular regions (A-D) and in basal
ganglia, thalami and pons (E&F).
Materials and Methods
Genomic DNA was extracted from peripher-
al blood using an AutoGenFlex STAR automat-
ed DNA extractor (AutoGen, Inc.)  Exons of the
NOTCH3  gene  reported  to  contain  disease
causing mutations (i.e., exons 2-5, 8, 11, 14,
18, 19, 22 and 23, were amplified by the poly-
merase chain reaction (PCR) and screened for
mutations  using  dHPLC  (WAVE;
Transgenomic, Inc.) and Surveyor endonucle-
ase digestion. Exons exhibiting altered elution
were sequenced using a commercially avail-
able  kit  (A  1)  and  di-deoxy  terminators.
Sequences  were  analyzed  on  an  automated
DNA sequencer (ABI) and compared to normal
sequence.
Results
Affected individuals were heterozygous for a
G  to  C  mutation  at  nucleotide  1790  of  the
NOTCH3  gene  (c.1790G>C)  that  changes  a
codon  for  cysteine  (TGC)  to  one  for  serine
(TCC)  at  amino  acid  position  597
(p.Cys597Ser). This mutation was not detected
in 120 ethnically related controls.
Discussion
The family described in this report showed
various  characteristics  that  are  typical  of
CADASIL,  an  autosomal  dominant  pattern,
recurrent ischemic stroke, migraine, cognitive
impairment  and  premature  death  within  10
years after onset.  One patient presented with
late onset migraine with aura had an abnormal
brain MRI, a feature along with family history
is suggestive of this diagnosis.12 Positive brain
MRI finding in asymptomatic individual indi-
cate that NOTCH3 signaling may start up to a
decade prior to clinical presentation.3
The C597S, NOTCH3 mutation in this fami-
ly is likely the causative mutation as its co-seg-
regate  with  the  clinical  phenotype  and  its
absence  in  120  ethnically  related  control.
Furthermore,  C597S  is  highly  evolutionary
conserved  in  the  NOTCH3  gene,  located  in
Exon 115 and predict change of cysteine to one
of  serine  at  amino  acid  position  597
(nucleotide  1790  of  the  NOTCH3  gene
(c1790G>C).  The loss of cysteine residue may
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[page 22] [Neurology International 2011; 3:e6]disturb the di-sulfate bond in EGF-like repeat
at EGF-14 domain.6,12 In patients with sugges-
tive  clinical  and  MRI  findings  of  CADASIL
necessitate either genes testing and/or elec-
tron  microscopy  or  immuno-histochemical
examination of a skin biopsy.  Mutation of a
pathogenic NOTCH3 gene gives the definite
diagnosis  but  the  great  number  of  different
mutations (>150) makes the search for less
common  mutation  cumbersome.    The  most
efficient  strategy  in  some  populations  will
depend in the patient’s family history, founder
mutations  or  the  mutational  background  in
patients ethnic group when certain mutations
are  prevalent5,6,12 as  there  is  a  variation  in
mutational spectrum between different ethnic
group.9 The mutation hot-spots regions: Exons
3,4,5, & 8 of the NOTCH3 gene should be ana-
lyzed first, then Exons 6, 11 and 18 should be
tested.12 The previous reported mutations in
Arabs  are  located  in  Exon  3  &413,14 of  the
NOTCH3 gene and had been reported previ-
ously in different ethnic groups.  The finding
of a noted novel mutation in Exon 11 in this
family  will  further  increase  the  spectrum  of
genetic finding in CADASIL.
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Figure  1.  Family  pedi-
gree  TIA,  transient
ischemic  stroke;  S:
stroke; M, migraine; D,
dementia;  Dep:
Depression.  Numbers
at the top indicate age
of  death  or  at  time  of
examinations.
Figure 2. Representative magnetic resonance imaging scans from family members. (A)
From sister (III: 32 in Figure 1). Note multiple lacunar lesions in deep white matter. (B)
(Index case III-37). Note multiple periventricular ischemic lesions C & D (from patient
III-38). Scans (E & F) (From mother II-52) showing different ischemic lesions in brain
and brain stem.